$24,750.00 | '
Delayed Sleep-Wake Phase Disorder | Executive Insights | US/EU5 | 2021
- DSWPD is a type of circadian rhythm sleep-wake disorder in which the sleep-wake cycle is delayed. DSWPD occurs more commonly in adolescents than in adults. In addition, the condition is highly comorbid with some psychiatric conditions, such as MDD and ASD.
- Although interviewed sleep specialists commonly diagnose DSWPD, they cite challenges in differentiating circadian DSWPD from noncircadian (i.e., behavioral) DSWPD. Interviewed psychiatrists usually consider DSWPD as secondary to a psychiatric disorder.
- No drug is currently approved for the management of DSWPD in the United States and EU5. Melatonin and some nonpharmacological approaches (e.g., light therapy) are commonly utilized in the treatment of DSWPD. However, the patient journey may differ depending on the presence or absence of a comorbid psychiatric disorder.
- Interviewed physicians cite multiple areas of unmet need in DSWPD, so opportunities exist for drug development in DSWPD. Of note, interviewed physicians have high expectations for an emerging drug in DSWPD.
Related Market Assessment Reports
Report
Systemic Lupus Erythematosus – Current Treatment – Treatment Algorithms: Claims Data Analysis – Systemic Lupus Erythematosus (US)
Systemic lupus erythematosus (SLE) is an autoimmune disease that affects multiple organ systems of the body. Symptoms range from general malaise to serious renal and CNS manifestations…
Report
Chronic Kidney Disease – Current Treatment – Treatment Algorithms: Claims Data Analysis – Chronic Kidney Disease (US)
Chronic kidney disease (CKD) is caused by structural or functional abnormalities in the kidney that impair its ability to filter blood. The CKD drug market primarily comprises therapies, which are…
Report
Multiple Sclerosis – Current Treatment – Treatment Algorithms: Claims Data Analysis – Multiple Sclerosis (US)
The multiple sclerosis (MS) therapy market comprises more than 20 immunomodulatory disease-modifying therapies (DMTs), and more are in the pipeline. A variety of drug classes each hold a niche…
